SheerVision, Inc. (SVSO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2009 | 57.34 Thousand USD | 30.25% |
| 2008 | 44.03 Thousand USD | 116.6% |
| 2007 | -265.26 Thousand USD | 76.2% |
| 2006 | -1.11 Million USD | -18626.92% |
| 2005 | -5952.00 USD | 50.89% |
| 2004 | -12.12 Thousand USD | -99.74% |
| 2003 | -6068.00 USD | 42.84% |
| 2002 | -10.61 Thousand USD | 14.73% |
| 2001 | -12.45 Thousand USD | 14.44% |
| 2000 | -14.55 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2010 Q2 | 91.35 Thousand USD | 23.1% |
| 2010 Q3 | 92.71 Thousand USD | 1.49% |
| 2010 Q1 | 74.21 Thousand USD | 29.41% |
| 2009 Q2 | 4842.00 USD | 103.7% |
| 2009 Q4 | 57.34 Thousand USD | 516.42% |
| 2009 Q3 | -13.77 Thousand USD | -384.43% |
| 2009 FY | 57.34 Thousand USD | 30.25% |
| 2009 Q1 | -130.79 Thousand USD | -397.05% |
| 2008 FY | 44.03 Thousand USD | 116.6% |
| 2008 Q1 | -275.75 Thousand USD | -3.96% |
| 2008 Q4 | 44.03 Thousand USD | 126.82% |
| 2008 Q3 | -164.17 Thousand USD | 20.44% |
| 2008 Q2 | -206.35 Thousand USD | 25.17% |
| 2007 Q2 | -277.61 Thousand USD | 57.22% |
| 2007 Q3 | -199.53 Thousand USD | 28.13% |
| 2007 FY | -265.26 Thousand USD | 76.2% |
| 2007 Q4 | -265.26 Thousand USD | -32.94% |
| 2007 Q1 | -648.99 Thousand USD | 41.77% |
| 2006 FY | -1.11 Million USD | -18626.92% |
| 2006 Q4 | -1.11 Million USD | -190.13% |
| 2006 Q3 | 1.23 Million USD | -13.62% |
| 2006 Q2 | 1.43 Million USD | 0.0% |
| 2006 Q1 | - USD | 100.0% |
| 2005 Q1 | -11.71 Thousand USD | 2.78% |
| 2005 FY | -5952.00 USD | 50.89% |
| 2005 Q4 | -5375.00 USD | 9.69% |
| 2005 Q2 | -11.51 Thousand USD | 1.71% |
| 2005 Q3 | -5952.00 USD | 48.32% |
| 2004 FY | -12.12 Thousand USD | -99.74% |
| 2004 Q4 | -12.05 Thousand USD | 0.55% |
| 2004 Q3 | -12.12 Thousand USD | 1.63% |
| 2004 Q2 | -12.32 Thousand USD | -131.42% |
| 2004 Q1 | -5324.00 USD | 3.74% |
| 2003 Q3 | -6068.00 USD | 4.05% |
| 2003 Q1 | -4069.00 USD | 60.79% |
| 2003 FY | -6068.00 USD | 42.84% |
| 2003 Q2 | -6324.00 USD | -55.42% |
| 2003 Q4 | -5531.00 USD | 8.85% |
| 2002 Q3 | -10.61 Thousand USD | 0.35% |
| 2002 Q1 | -6421.00 USD | 46.89% |
| 2002 Q4 | -10.37 Thousand USD | 2.24% |
| 2002 Q2 | -10.65 Thousand USD | -65.91% |
| 2002 FY | -10.61 Thousand USD | 14.73% |
| 2001 Q1 | -14.5 Thousand USD | -3.09% |
| 2001 Q2 | -13.08 Thousand USD | 9.75% |
| 2001 Q3 | -12.45 Thousand USD | 4.86% |
| 2001 Q4 | -12.09 Thousand USD | 2.89% |
| 2001 FY | -12.45 Thousand USD | 14.44% |
| 2000 Q1 | -15.67 Thousand USD | 2.86% |
| 2000 Q4 | -14.06 Thousand USD | 3.35% |
| 2000 Q3 | -14.55 Thousand USD | 3.28% |
| 2000 FY | -14.55 Thousand USD | 0.0% |
| 2000 Q2 | -15.04 Thousand USD | 3.98% |
| 1999 Q4 | -16.13 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | 88.043% |
| Ansell Limited | -54.99 Million USD | 100.104% |
| Ansell Limited | -55.1 Million USD | 100.104% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 100.157% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 154.565% |
| Psykey, Inc. | 634.59 Thousand USD | 90.963% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.995% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.995% |
| Encision Inc. | 1.29 Million USD | 95.557% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | 97.516% |
| Innovative MedTech Inc. | 1.76 Million USD | 96.75% |
| LifePoint, Inc. | -3.26 Million USD | 101.757% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 98.831% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | 97.347% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 232.433% |
| Reflect Scientific, Inc. | -1.03 Million USD | 105.539% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.993% |
| Sector 10, Inc. | 163 Thousand USD | 64.817% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.014% |
| United Health Products, Inc. | 660.56 Thousand USD | 91.318% |
| Vasamed, Inc. | 22.12 Thousand USD | -159.24% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | 97.82% |
| Yubo International Biotech Limited | 772.27 Thousand USD | 92.574% |